Subscription or Fee Access
Clinical and Immunological Response of HIV/AIDS Patients Receiving Anti-Retroviral Therapy (ART) at Nyangana Mission Hospital in Namibia
There is strong evidence to show that antiretroviral therapy (ART) improves the survival and quality of life of people living with HIV/AIDS (PLWHA). Namibia, one of the countries with high rate of HIV/AIDS, has embarked on a large scale public sector roll out of ART. The Catholic Health Services is implementing an HIV/AIDS treatment program in Nyangana rural district. The objectives of the study are to describe baseline clinical profile and subsequent clinical response of HIV/AIDS patients receiving ART and to determine baseline immunological profile. Standardised patient files and registers were used to abstract data as per selected variables into an Excel database. Epi Info and SPSS were used to analyse data. ART is currently reaching 46% of PLWHA in need of it in Nyangana District. At baseline, the mean age is 36 years, mean weight is 48 kg and median CD4 cell count was 131 cells or µL (IDR: 75-216). Females represents 69% of patients, and are more likely to have higher CD4 count at baseline (p less than 0.0001). Also, they are more likely to survive compared to males (OR: 2.3). The mean duration on ART was 20.8 and 5.1 months respectively, for those still alive and those who died. A mortality rate of 23.5% occurred mainly in the first 3 months of initiation (60%) with TB (37.9%) and gastroenteritis (18.2%) as leading causes of death. These findings supports the facts, that high quality ART Services can be implemented in a rural setting in Namibia.
HIV/AIDS, HAART, Clinical, Immunological, Adherence Response/outcome, Patient cohort, Weight gain, CD4 cell Count trend
Disclaimer/Regarding indexing issue:
We have provided the online access of all issues and papers to the indexing agencies (as given on journal web site). It’s depend on indexing agencies when, how and what manner they can index or not. Hence, we like to inform that on the basis of earlier indexing, we can’t predict the today or future indexing policy of third party (i.e. indexing agencies) as they have right to discontinue any journal at any time without prior information to the journal. So, please neither sends any question nor expects any answer from us on the behalf of third party i.e. indexing agencies.Hence, we will not issue any certificate or letter for indexing issue. Our role is just to provide the online access to them. So we do properly this and one can visit indexing agencies website to get the authentic information.